Exhaustive exercise abolishes REV‐ERB‐α circadian rhythm and shifts the kynurenine pathway to a neurotoxic profile in mice

The circadian-regulated transcriptional repressor REV-ERB-α is a key mediator of skeletal muscle oxidative capacity, enhancing exercise performance when activated. Conversely its global genetic ablation leads to impaired performance. Simultaneously the kynurenine (KYN) pathway, involved in tryptophan degradation, produces neurotoxic metabolites under stress and inflammation, contributing to CNS dysfunction and fatigue. These mechanisms may underlie the fatigue and performance impairments caused by exhaustive exercise (EE). This study investigated the interplay between REV-ERB-α and the KYN pathway in acute and chronic EE models. Time course analyses revealed that EE downregulated REV-ERB-α in skeletal muscle, correlated with KYN pathway alterations. Notably KYN metabolism shifted towards a neurotoxic profile, characterized by reduced KYN aminotransferase 1 (KAT1) and increased KYN 3-monooxygenase (KMO) expression in skeletal muscle, with increased KYN levels in the hippocampus. In vitro experiments using C2C12 myoblasts showed that REV-ERB-α knockout upregulated KAT1 and KMO, whereas overexpression selectively reduced KMO. Pharmacological activation of REV-ERB-α with SR9009 upregulated KAT1 in skeletal muscle and reduced KMO in the hippocampus of mice. These findings reveal a dynamic relationship between REV-ERB-α and the KYN pathway, linking peripheral and central responses to EE. This study highlights REV-ERB-α and the KYN pathway as critical regulators of exercise-induced fatigue and suggests potential therapeutic targets to mitigate its effects, offering novel insights into the molecular basis of performance impairments associated with EE. KEY POINTS: Excessive exercise can impair performance and induce fatigue; however the underlying biological mechanisms remain incompletely understood. Although REV-ERB-α activation enhances skeletal muscle oxidative capacity and exercise performance, its deletion impairs both parameters. This study demonstrates that excessive exercise decreases REV-ERB-α levels in skeletal muscle and disrupts the kynurenine (KYN) pathway by downregulating KYN aminotransferase 1 (KAT1), an enzyme involved in a neuroprotective branch of the pathway. These alterations affect both skeletal muscle and the brain, suggesting a potential link between physical fatigue and brain function. REV-ERB-α suppresses KYN 3-monooxygenase (KMO), a key enzyme in the KYN pathway that promotes the formation of potentially neurotoxic metabolites, thereby revealing a novel mechanism and a potential therapeutic target.

Authors

Institutions

Publication Details

Journal
The Journal of Physiology
Published
2025-06-24
DOI
https://doi.org/10.1113/jp288290
Citations
3
Primary Topic
Tryptophan and brain disorders
Type
article
Field-Weighted Citation Impact
1.73

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exhaustive exercise abolishes REV‐ERB‐α circadian rhythm and shifts the kynurenine pathway to a neurotoxic profile in mice

Leandro Pereira de Moura, Ivo Vieira de Sousa Neto, Adelino Sánchez Ramos da Silva, Alisson L. da Rocha et al.
3 citations
The Journal of Physiology
Tryptophan and brain disorders
1.73
article

Exhaustive exercise abolishes REV‐ERB‐α circadian rhythm and shifts the kynurenine pathway to a neurotoxic profile in mice

Leandro Pereira de Moura, Ivo Vieira de Sousa Neto, Adelino Sánchez Ramos da Silva, Alisson L. da Rocha, Bruno B. Marafon, John Pauli, Ana P. Pinto, Vítor Rosetto Muñoz, Lilian Eslaine Costa Mendes da Silva, Ellen Cristini de Freitas, Fernando Moreira Simabuco, Donato A. Rivas, Dennys E. Cintra, Eduardo Rochete Ropelle
article en
3 citations

Abstract

The circadian-regulated transcriptional repressor REV-ERB-α is a key mediator of skeletal muscle oxidative capacity, enhancing exercise performance when activated. Conversely its global genetic ablation leads to impaired performance. Simultaneously the kynurenine (KYN) pathway, involved in tryptophan degradation, produces neurotoxic metabolites under stress and inflammation, contributing to CNS dysfunction and fatigue. These mechanisms may underlie the fatigue and performance impairments caused by exhaustive exercise (EE). This study investigated the interplay between REV-ERB-α and the KYN pathway in acute and chronic EE models. Time course analyses revealed that EE downregulated REV-ERB-α in skeletal muscle, correlated with KYN pathway alterations. Notably KYN metabolism shifted towards a neurotoxic profile, characterized by reduced KYN aminotransferase 1 (KAT1) and increased KYN 3-monooxygenase (KMO) expression in skeletal muscle, with increased KYN levels in the hippocampus. In vitro experiments using C2C12 myoblasts showed that REV-ERB-α knockout upregulated KAT1 and KMO, whereas overexpression selectively reduced KMO. Pharmacological activation of REV-ERB-α with SR9009 upregulated KAT1 in skeletal muscle and reduced KMO in the hippocampus of mice. These findings reveal a dynamic relationship between REV-ERB-α and the KYN pathway, linking peripheral and central responses to EE. This study highlights REV-ERB-α and the KYN pathway as critical regulators of exercise-induced fatigue and suggests potential therapeutic targets to mitigate its effects, offering novel insights into the molecular basis of performance impairments associated with EE. KEY POINTS: Excessive exercise can impair performance and induce fatigue; however the underlying biological mechanisms remain incompletely understood. Although REV-ERB-α activation enhances skeletal muscle oxidative capacity and exercise performance, its deletion impairs both parameters. This study demonstrates that excessive exercise decreases REV-ERB-α levels in skeletal muscle and disrupts the kynurenine (KYN) pathway by downregulating KYN aminotransferase 1 (KAT1), an enzyme involved in a neuroprotective branch of the pathway. These alterations affect both skeletal muscle and the brain, suggesting a potential link between physical fatigue and brain function. REV-ERB-α suppresses KYN 3-monooxygenase (KMO), a key enzyme in the KYN pathway that promotes the formation of potentially neurotoxic metabolites, thereby revealing a novel mechanism and a potential therapeutic target.

The Journal of PhysiologyVol. 603(14)
Universidade de Ribeirão Preto (BR), Universidade de São Paulo (BR), Universidade Estadual de Campinas (UNICAMP) (BR), Biomedical Research Institute (US), Carilion Clinic (US), Virginia Tech (US), Universidade Federal de São Paulo (BR)
Fundação de Amparo à Pesquisa do Estado de São Paulo, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico
Good health and well-being
Openalex Percentile: Top 15%
Tryptophan and brain disorders
1.73
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.